Psychosocial Impact of Dysarthria: The Patient-Reported Outcome as Part of the Clinical Management, Neurodegenerative Diseases, pp.1-10, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02285034
Distorsions de l'espace vocalique : Quelles mesures ? Application à la dysarthrie, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02436294
Speech disorders in Parkinson's disease: Early diagnostics and effects of medication and brain stimulation, Journal of Neural Transmission, vol.124, issue.3, pp.303-334, 2017. ,
, , 2012.
, Sentence Intelligibility Before and After Voice Treatment in Speakers with Idiopathic Parkinson's Disease, Journal of Voice, vol.26, issue.2, pp.214-219
The French version of Speech Handicap Index: Validation and comparison with the Voice Handicap Index, Folia Phoniatrica et Logopaedica, pp.20-25, 2012. ,
URL : https://hal.archives-ouvertes.fr/halshs-00683745
Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): A pilot study, Neurosurgery & Psychiatry, vol.72, issue.1, pp.31-36, 2002. ,
ROCme! : Logiciel pour l'enregistrement et la gestion de corpus oraux, pp.19-20, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01240250
, , 2014.
Contraste entre les effets respectifs de l'hypodopaminergie due à la maladie de Parkinson et de l'apport thérapeutique par L-Dopa, Revue de Laryngologie Otologie Rhinologie, vol.135, issue.2, pp.63-70 ,
Comparison of speech and language therapy techniques for speech problems in Parkinson's disease, Cochrane Database of Systematic Reviews, 2012. ,
Voice characteristics in the progression of Parkinson's disease, International Journal of Language & Communication Disorders, vol.35, issue.3, pp.407-418, 2000. ,
Acoustic voice analysis in untreated patients with Parkinson's disease, La maladie de Parkinson. Inserm -La science pour la santé, vol.3, pp.111-116, 1997. ,
Hypophonia in Parkinson's disease: Neural correlates of voice treatment revealed by PET, Neurology, vol.60, issue.3, pp.432-440, 2003. ,
Prosodic Characteristics of Mandarin Declarative and Interrogative Utterances in Parkinson's Disease. Interspeech, pp.3870-3874, 2019. ,
Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis, Human Brain Mapping, vol.31, issue.2, pp.222-236, 2010. ,
Comparison of two forms of intensive speech treatment for Parkinson Disease, Journal of Speech, Language, and Hearing Research, vol.38, issue.6, pp.1232-1251, 1995. ,
Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age-matched controls, Movement Disorders, vol.16, issue.1, pp.79-83, 2001. ,
Speech treatment in Parkinson's disease: Randomized controlled trial (RCT), Movement Disorders, vol.33, issue.11, pp.1777-1791, 2018. ,
La dysphonie parkinsonienne, Les troubles de la parole et de la déglutition dans la maladie de Parkinson, pp.131-143, 2005. ,
Effects of Intensive Voice Treatment (the Lee Silverman Voice Treatment [LSVT]) on Vowel Articulation in Dysarthric Individuals with Idiopathic Parkinson Disease: Acoustic and Perceptual Findings, Journal of Speech, Language, and Hearing Research, vol.50, issue.4, pp.899-912, 2007. ,
The Effects of Intensive Voice Treatment on Facial Expressiveness in Parkinson Disease, Cognitive and Behavioral Neurology, vol.16, issue.3, pp.177-188, 2003. ,
Lee Silverman Voice Treatment for people with Parkinson's: Audit of outcomes in a routine clinic, International Journal of Language & Communication Disorders, vol.50, issue.2, pp.215-225, 2015. ,
Voice analysis and videolaryngostroboscopy in patients with Parkinson's disease, European Archives of Oto-Rhino-Laryngology, vol.259, issue.6, pp.290-293, 2002. ,